ITK Deficiency: How can EBV be Treated Before Lymphoma?

Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia

(2014) N. K. Serwas et al.   BLOOD

Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders

(2014) Oded Shamriz et al.   CLINICAL IMMUNOLOGY

Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects

(2014) Sujal Ghosh et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Severe EBV hepatitis treated with valganciclovir

(2012) R. Pisapia et al.   INFECTION

IL-2-Inducible T-Cell Kinase Deficiency with Pulmonary Manifestations due to Disseminated Epstein-Barr Virus Infection

(2012) D. Mansouri et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases

(2012) R M Linka et al.   LEUKEMIA

IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach

(2010) P. Stepensky et al.   HAEMATOLOGICA

Girls homozygous for an IL-2–inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation

(2009) Kirsten Huck et al.   JOURNAL OF CLINICAL INVESTIGATION

Valacyclovir Pharmacokinetics and Exploratory Pharmacodynamics in Young Adults With Epstein-Barr Virus Infectious Mononucleosis

(2009) Heather E. Vezina et al.   JOURNAL OF CLINICAL PHARMACOLOGY